Speciality: Hematology
Description:
A warm welcome to all the medical professionals in this memorable scientific session on the management of venous thromboembolism in patients of general surgery.
Venous thromboembolism is the most common cause of death observed in surgical patients. The risk of venous thromboembolism (VTE) among the population of postoperative patients is heterogeneous and depends on intrinsic patient factors.
The risk is determined by the combination of different factors and features such as the use of prophylaxis, perioperative care, etc which are related to the type of surgery. It is evident that extended use of prophylaxis, early mobilization, and the implication of improved perioperative care can help in reducing the risk of VTE in surgical patients.
Thus, depending on the risk for VTE and major bleeding in surgical patients combined methods of mechanical and pharmacological prophylaxis or only mechanical prophylaxis may be preferred.
Therefore, listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
1.
Watch for Psoriasis After Cancer Immunotherapy, Study Says
2.
AI model combines clinical and magnetic resonance data to improve prediction of breast cancer recurrence
3.
Disparities in use of MRI to detect prostate cancer: Race and location may influence testing
4.
Revolutionary Cancer Tx Could Transform Autoimmune Disease
5.
FDA Approves Monthly Dosing of Rybrevant Faspro for NSCLC
1.
Therapeutic Innovations Through Germline Predisposition in Acute Leukemias and Myeloid Neoplasms
2.
Metabolic Symbiosis Within the Tumor Niche: Mechanisms, Clinical Implications, and Therapeutic Opportunities
3.
Bridging the Gap Between Cancer Treatment-Induced Cardiotoxicity and Regenerative Medicine
4.
Glycopyrrolate: The Secret Weapon for Excessive Sweating
5.
IGSF8: A Rising Star in Cancer Immunotherapy - Harnessing the Innate Immune System
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part III
2.
What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?
3.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion
4.
Role of Nimotuzumab in Management of Nasopharyngeal Cancer
5.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation